Stocktoria
NUTRA PHARMA CORP NPHC
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2001-10-09
NUTRA PHARMA CORP (NPHC) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $257,612 at a -794.8% net margin.
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$1M
Net margin-794.8%
Revenue trend · last 10y · up
How it ranks in Manufacturing · percentile among 1906 companies
Piotroski Fstronger than 27%
Net marginstronger than 11%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NPHC | NUTRA PHARMA CORP | 3/9 | — | — | — |
| NTRR | NEUTRA CORP. | 4/9 | — | — | — |
| RAJAF | Cordyceps Sunshine Biotech Holdings Co., Ltd. | 4/9 | -6.82 | — | — |
| PLSH | PANACEA LIFE SCIENCES HOLDINGS, INC. | 4/9 | -13.95 | — | — |
| FTLF | FITLIFE BRANDS, INC. | 3/9 | 1.99 | 51.6 | -75.3% |
| BON | Bon Natural Life Ltd | 4/9 | 4.25 | — | -21.7% |
| CHUC | Charlie's Holdings, Inc. | 3/9 | -1.35 | 13.2 | — |
FAQ
Is NPHC financially healthy?
NUTRA PHARMA CORP's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does NPHC pay a dividend?
No, NUTRA PHARMA CORP does not currently pay a dividend.
How profitable is NPHC?
In FY2025, NUTRA PHARMA CORP had a net margin of -794.8%.
Source: SEC EDGAR filings · CIK 0001119643 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.